Cargando…
Design and synthesis of ERα agonists: Effectively reduce lipid accumulation
In recent years, the incidence of non-alcoholic fatty liver disease (NAFLD) has been increasing worldwide. Hepatic lipid deposition is a major feature of NAFLD, and insulin resistance is one of the most important causes of lipid deposition. Insulin resistance results in the disruption of lipid metab...
Autores principales: | Yang, Jinfei, Yao, Weiwei, Yang, Huihui, Shen, Yajing, Zhang, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772986/ https://www.ncbi.nlm.nih.gov/pubmed/36569962 http://dx.doi.org/10.3389/fchem.2022.1104249 |
Ejemplares similares
-
Design, synthesis and evaluation of 3-phenoxypyrazine-2-carboxamide derivatives as potent TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2022) -
Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARα and SREBP1
por: Zhang, Xiaonan, et al.
Publicado: (2019) -
Small-molecule drugs development for Alzheimer's disease
por: Yao, Weiwei, et al.
Publicado: (2022) -
Design, synthesis and properties investigation of N(α)-acylation lysine based derivatives
por: Shi, Ting-Ting, et al.
Publicado: (2019) -
Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
por: Visser, Koch, et al.
Publicado: (2013)